Physician profile
H Adam Ubert
NPI 1053545806
$6,151.40
in general payments reported to CMS, 2019-2025
12 companies · $502 in 2025
The $502 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,060 · 2021: $31.58 · 2022: $63.44 · 2023: $252 · 2024: $242 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $969 · Gift: $27.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $968.52 |
| Gift | $27.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,500.00 | 2019 | |
| W. L. Gore & Associates, INC. | $538.22 | 2019 | |
| Baxter Healthcare | $265.30 | 2024-2025 | Preveleak |
| Abiomed | $204.89 | 2023-2025 | Impella |
| Helios Cardio INC | $147.55 | 2023 | |
| Atricure, INC. | $135.31 | 2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| On Target Laboratories, INC | $112.47 | 2025 | Cytalux |
| Livanova USA, INC. | $95.02 | 2021-2022 | |
| Edwards Lifesciences Corporation | $66.85 | 2023-2025 | Sapien 3 Ultra Resilia, Evoque |
| Medtronic, INC. | $46.41 | 2024-2025 | Vitalflow Console |
| Medtronic Vascular, INC. | $21.69 | 2019 | |
| Cardiva Medical, INC. | $17.69 | 2024 | Cardiva Vascade 6/7f Vcs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw H Ubert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.